|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pharoah PD, Dunning AM, Ponder BA and
Easton DF: Association studies for finding cancer-susceptibility
genetic variants. Nat Rev Cancer. 4:850–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Risch N: The genetic epidemiology of
cancer: interpreting family and twin studies and their implications
for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev.
10:733–741. 2001.PubMed/NCBI
|
|
4
|
Nigg EA: Centrosome aberrations: cause or
consequence of cancer progression? Nat Rev Cancer. 2:815–825. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou H, Kuang J, Zhong L, et al: Tumour
amplified kinase STK15/BTAK induces centrosome amplification,
aneuploidy and transformation. Nat Genet. 20:189–193. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bischoff JR, Anderson L, Zhu Y, et al: A
homologue of Drosophila aurora kinase is oncogenic and amplified in
human colorectal cancers. EMBO J. 17:3052–3065. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li D, Zhu J, Firozi PF, et al:
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human
pancreatic cancer. Clin Cancer Res. 9:991–997. 2003.PubMed/NCBI
|
|
8
|
Ewart-Toland A, Briassouli P, de Koning
JP, et al: Identification of Stk6/STK15 as a candidate
low-penetrance tumor-susceptibility gene in mouse and human. Nat
Genet. 34:403–412. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Venter JC, Adams MD, Myers EW, et al: The
sequence of the human genome. Science. 291:1304–1351. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kimura MT, Mori T, Conroy J, Nowak NJ,
Satomi S, Tamai K and Nagase H: Two functional coding single
nucleotide polymorphisms in STK15 (Aurora A) coordinately increase
esophageal cancer risk. Cancer Res. 65:3548–3554. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akkiz H, Bayram S, Bekar A, Akgöllü E and
Ozdil B: Relationship between functional polymorphism in the Aurora
A gene and susceptibility of hepatocellular carcinoma. J Viral
Hepat. 17:668–674. 2010.
|
|
12
|
Chava S, Mohan V, Pasupuleti N, et al:
Evaluation of Aurora-A gene polymorphism and esophageal cancer risk
in a South Indian population. Genet Test Mol Biomarkers.
15:185–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L: Genetic polymorphisms and disease
risks: STK15 gene and risk for gastric cancer, MMP9 gene and risk
for thoracic aortic aneurysm and thoracic aortic dissection
(unpublished PhD thesis). China Medical University; 2005, (In
Chinese).
|
|
14
|
Chen J, Sen S, Amos CI, Wei C, Jones JS,
Lynch P and Frazier ML: Association between Aurora-A kinase
polymorphisms and age of onset of hereditary nonpolyposis
colorectal cancer in a Caucasian population. Mol Carcinog.
46:249–256. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen XB, Chen GL, Liu JN, Yang JZ, Yu DK,
Lin DX and Tan W: Genetic polymorphisms in STK15 and MMP-2
associated susceptibility to esophageal cancer in Mongolian
population. Zhonghua Yu Fang Yi Xue Za Zhi. 43:559–564. 2009.(In
Chinese). PubMed/NCBI
|
|
16
|
Ewart-Toland A, Dai Q, Gao YT, et al:
Aurora-A/STK15 T+91A is a general low penetrance cancer
susceptibility gene: a meta-analysis of multiple cancer types.
Carcinogenesis. 26:1368–1373. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hienonen T, Salovaara R, Mecklin JP,
Järvinen H, Karhu A and Aaltonen LA: Preferential amplification of
AURKA 91A (Ile31) in familial colorectal cancers. Int J Cancer.
118:505–508. 2006. View Article : Google Scholar
|
|
18
|
Ju H, Cho H, Kim YS, et al: Functional
polymorphism 57Val>Ile of aurora kinase A associated with
increased risk of gastric cancer progression. Cancer Lett.
242:273–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao X, Sun T, Wang Y, Zhang X, Tan W and
Lin D: Functional STK15 Phe31Ile polymorphism is associated with
the occurrence and advanced disease status of esophageal squamous
cell carcinoma. Cancer Res. 64:2680–2683. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sang YH, Gu HY, Ding GW, Yang WT, Chen SC
and Chen YB: Association between the esophageal cancer
susceptibility and the STK15 T+91A polymorphism. Zhonghua Shi Yan
Wai Ke Za Zhi. 29:12202012.(In Chinese).
|
|
21
|
Wang N, Wang GY, Guo W, Dong XJ and Li Y:
Study on the association between STK15 Phe31Ile polymorphisms and
esophageal squamous cell carcinoma. Zhonghua Liu Xing Bing Xue Za
Zhi. 28:394–397. 2007.(In Chinese). PubMed/NCBI
|
|
22
|
Webb EL, Rudd MF and Houlston RS:
Case-control, kin-cohort and meta-analyses provide no support for
STK15 F31I as a low penetrance colorectal cancer allele. Br J
Cancer. 95:1047–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang WJ, Miao XP, Sun T, et al:
Association between genetic polymorphism in STK15 and risk of
colorectal cancer in a Chinese population. Zhonghua Zhong Liu Za
Zhi. 28:43–46. 2006.(In Chinese). PubMed/NCBI
|
|
24
|
Institute of Human Genetics. HWE
calculator. http://ihg.gsf.de/cgi-bin/hw/hwa1.pluri.
Accessed February 20, 2014
|
|
25
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar
|
|
26
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
27
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Egan KM, Newcomb PA, Ambrosone CB, et al:
STK15 polymorphism and breast cancer risk in a population-based
study. Carcinogenesis. 25:2149–2153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanaka T, Kimura M, Matsunaga K, Fukada D,
Mori H and Okano Y: Centrosomal kinase AIK1 is overexpressed in
invasive ductal carcinoma of the breast. Cancer Res. 59:2041–2044.
1999.PubMed/NCBI
|
|
32
|
Buschhorn HM, Klein RR, Chambers SM, Hardy
MC, Green S, Bearss D and Nagle RB: Aurora-A over-expression in
high-grade PIN lesions and prostate cancer. Prostate. 64:341–346.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang W, Qiu H, Ding H, Sun B, Wang L, Yin
J and Gu H: Association between the STK15 F31I polymorphism and
cancer susceptibility: a meta-analysis involving 43,626 subjects.
PLoS One. 8:e827902013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu L, Zhou X, Jiang F, Xu L and Yin R:
STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of
74,896 subjects. Cancer Epidemiol. 38:111–117. 2014. View Article : Google Scholar
|
|
35
|
Hirschhorn JN, Lohmueller K, Byrne E and
Hirschhorn K: A comprehensive review of genetic association
studies. Genet Med. 4:45–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boccia S, De Feo E, Gallì P, Gianfagna F,
Amore R and Ricciardi G: A systematic review evaluating the
methodological aspects of meta-analyses of genetic association
studies in cancer research. Eur J Epidemiol. 25:765–775. 2010.
View Article : Google Scholar : PubMed/NCBI
|
